Source: IQVIA database as of and is subject to change without notice. *Based on total prescriptions of subcutaneous calcitonin gene-related peptide (CGRP) antibody injections written after. TRICARE ® is a registered trademark of the Department of Defense (DoD), DHA.Įmgality is the #1 prescribed CGRP antibody injection for preventive treatment of migraine * AND has best-in-class commercial access. Subject to additional terms and conditions, which can be found Offer void where prohibited by law and subject to change or discontinue without notice. This offer is invalid for Patients without commercial drug insurance or whose prescription claims for Emgality are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE ®/CHAMPUS, or any State Patient or Pharmaceutical Assistance Program. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. Patients that have commercial drug insurance but do not have coverage for Emgality may be able to pay as little as $0 for their first fill of a 30-day supply of Emgality. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate annual cap of $4,900. Patients that have commercial drug insurance coverage for Emgality may be able to pay as little as $0 for a 30-day supply of Emgality. Offer good for up to 12 months of Emgality from Patient qualification into the program.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |